References

Characterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system

2013 · External reference

Importance of glutamine in synaptic vesicles revealed by functional studies of SLC6A17 and its mutations pathogenic for intellectual disability

2023 · External reference

Synaptic vesicle protein NTT4/XT1 (SLC6A17) catalyzes Na+-coupled neutral amino acid transport

10.1074/jbc.m806407200 · 2009 · External reference

10.1124/mol.108.050005

10.1124/mol.108.050005 · External reference

Homozygous SLC6A17 mutations cause autosomal-recessive intellectual disability with progressive tremor, speech impairment, and behavioral problems

10.1016/j.ajhg.2015.01.010 · 2015 · External reference

10.3109/10253890.2015.1105211

10.3109/10253890.2015.1105211 · External reference

The SLC6A15-SLC6A20 neutral amino acid transporter subfamily: functions, diseases, and their therapeutic relevance

10.1124/pharmrev.123.000886 · 2023 · External reference

B0AT2 (SLC6A15) Is localized to neurons and astrocytes, and is involved in mediating the effect of leucine in the brain

2013 · External reference

10.1006/geno.2000.6387

10.1006/geno.2000.6387 · External reference

The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2)

10.1042/bj20051273 · 2006 · External reference

10.1016/j.bbrc.2005.09.128

10.1016/j.bbrc.2005.09.128 · External reference

10.1038/s41586-021-03819-2

10.1038/s41586-021-03819-2 · External reference

Principles of alternating access in leut-fold transporters: commonalities and divergences

10.1016/j.jmb.2022.167746 · 2022 · External reference

Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2

10.1038/s41467-024-48921-x · 2024 · External reference

10.1101/2020.02.19.956946

10.1101/2020.02.19.956946 · External reference

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2

10.1038/s41421-022-00488-x · 2022 · External reference

Structural insight into the substrate recognition and transport mechanism of amino acid transporter complex ACE2-B0AT1 and ACE2-SIT1

2023 · External reference

Probing binding and occlusion of substrate in the human creatine transporter-1 by computation and mutagenesis

10.1002/pro.4842 · 2024 · External reference

Structure and gating dynamics of Na+/Cl– coupled neurotransmitter transporters

10.3389/fmolb.2019.00080 · 2019 · External reference

10.1038/nature03978

10.1038/nature03978 · External reference

10.1074/jbc.m311579200

10.1074/jbc.m311579200 · External reference

10.1074/jbc.m809423200

10.1074/jbc.m809423200 · External reference

Steady-state kinetic characterization of the mouse B0AT1 sodium-dependent neutral amino acid transporter

10.1007/s00424-005-1455-x · 2005 · External reference

10.1038/nature17629

10.1038/nature17629 · External reference

10.1038/nature06038

10.1038/nature06038 · External reference

10.1126/science.1166777

10.1126/science.1166777 · External reference

A non‐helical region in transmembrane helix 6 of hydrophobic amino acid transporter MhsT mediates substrate recognition

10.15252/embj.2020105164 · 2021 · External reference

10.1038/s41594-023-01011-w

10.1038/s41594-023-01011-w · External reference

Loratadine and analogues: Discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B0AT2

10.1021/jm501086v · 2014 · External reference

Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats

10.1007/s12272-010-0913-y · 2010 · External reference

Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine

10.1002/prp2.499 · 2019 · External reference

10.1038/s41586-022-04814-x

10.1038/s41586-022-04814-x · External reference